LNTH Q3 2020 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q3 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$89M+3.2% YoY

Gross Profit

$36M41.0% margin

Operating Income

-$5M-5.9% margin

Net Income

-$6M-7.2% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+34.1%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$5M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$880M

Total Liabilities

$366M

Stockholders' Equity

$514M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$86M	+3.2%
Gross Profit	$36M	$42M	-12.8%
Operating Income	-$5M	$9M	-161.6%
Net Income	-$6M	$5M	-231.5%

Revenue Segments

US Segment

$77M87%

International Segment

$11M13%